Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-06-10

Clinical Trial Update: Personalized Anti-Inflammatory Fibres in Ulcerative Colitis [NA]

View source ↗

Summary

A University of Alberta-sponsored clinical trial investigating personalized anti-inflammatory fibres for Ulcerative Colitis is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Personalized Anti-Inflammatory Fibres

Snippet

Sponsor: University of Alberta | Conditions: Ulcerative Colitis | NA | Status: RECRUITING